# Mirabegron

## Betmiga 25mg prolonged-release

#### 一般可用

| 藥品代碼       | OBET2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:---------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Treatment of overactive bladder with symptoms of urinary frequency， urgency， or urge urinary incontinence                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 用法用量       | 25-50 mg once daily. May be taken with or without food. Swallow whole， do not chew/divide/crush.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 肝功能異常     | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 腎功能異常     | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 禁忌           | Hypersensitivity to mirabegron or any component of the formulation， severe uncontrolled hypertension (systolic blood pressure >=180 mm Hg and/or diastolic blood pressure >=110 mm Hg)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 副作用         | >10%: Cardiovascular: Hypertension (9% to 11%) 1% to 10%: Cardiovascular: Tachycardia (2%) Central nervous system: Headache (4%)， dizziness (3%) Gastrointestinal: Constipation (2% to 3%)， xerostomia (3%)， diarrhea (2%) Genitourinary: Urinary tract infection (3% to 6%)， cystitis (2%) Neuromuscular & skeletal: Back pain (3%)， arthralgia (2%) Respiratory: Nasopharyngitis (4%)， sinusitis (3%) Miscellaneous: Flu-like syndrome (3%) <1% (Limited to important or life-threatening): ALT/AST increased， atrial fibrillation， breast cancer， cerebrovascular accident， GGT increased， glaucoma， LDH increased， leukocytoclastic vasculitis， lung cancer， nephrolithiasis， osteoarthritis， palpitations， prostate cancer， Stevens-Johnson syndrome， urinary retention， vaginal infection， vulvovaginal pruritus |
| 孕期用藥建議   | No (limited) human data – animal data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 哺乳期用藥建議 | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |

## BETMIGA 50mg prolonged-release

#### 一般可用

| 藥品代碼       | OBET5                                                                                                                                                                                                                                                                                                                                                                                                                                          |
|:---------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Neurogenic detrusor overactivity. Overactive bladder， Monotherapy or in combination with solifenacin， with symptoms of urge urinary incontinence， urgency， and urinary frequency.                                                                                                                                                                                                                                                          |
| 用法用量       | 25-50 mg once daily. May be taken with or without food. Swallow whole， do not chew， divide or crush.                                                                                                                                                                                                                                                                                                                                         |
| 肝功能異常     | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 腎功能異常     | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 禁忌           | Hypersensitivity to mirabegron or any components of the product.                                                                                                                                                                                                                                                                                                                                                                               |
| 副作用         | Common Cardiovascular: Hypertension (7% to 11.3% )， Tachycardia (1.2% to 2.2% ) Gastrointestinal: Constipation (1.2% to 4.7% )， Xerostomia (2.8% to 9.3% ) Neurologic: Headache (1.6% to 4.1% ) Renal: Urinary tract infectious disease (Adult， 2.9% to 8.4% ; pediatric， 24.4% ) Respiratory: Nasopharyngitis (3.5% to 5.8% ) Serious Neurologic: Cerebrovascular accident (0.4% ) Renal: Urinary retention Other: Cancer (0.1% to 1.3% ) |
| 孕期用藥建議   | No (limited) human data – animal data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                         |
| 哺乳期用藥建議 | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                           |

